Using a brain protection device during TAVR to prevent stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests if a special device placed during transcatheter aortic valve replacement (TAVR) can help prevent stroke. It is for adults with severe aortic stenosis who are already scheduled for TAVR.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe narrowing of your aortic valve (aortic stenosis) that causes symptoms.
- You are scheduled to have TAVR (a procedure to replace the valve through a catheter in your leg).
- You will receive the Sentinel Cerebral Protection System during the procedure.
- You are an adult who agrees to participate and signs a consent form.
- You have not had a stroke, brain bleed, brain tumor, encephalitis, or other brain disease in the last year.
- You have not had open-chest surgery or a previous heart valve replacement.
- Your heart's pumping strength (left ventricular ejection fraction) is above 30%.
- You can have an MRI scan and do not have severe claustrophobia.
- You are willing and able to attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called CHORDS that protects your brain during transcatheter aortic valve replacement (TAVR), a minimally invasive procedure to fix a narrow aortic valve. The device works by blocking debris that might travel to your brain during the procedure.
This trial tests a new filter device designed to catch debris that might travel to the brain during a minimally invasive aortic valve replacement (TAVR). The goal is to see if it can help reduce the risk of stroke.
This study enrolls older adults having a minimally invasive heart valve procedure (TAVI) to find “epigenetic” risk markers—signals in the body that may predict who is more likely to have complications during the procedure. If you qualify, your blood and/or samples may be studied to improve safety for future patients.
This study tests a new device called ShortCut to help doctors safely replace a failing bioprosthetic heart valve (a valve that was placed in your heart previously) using a minimally invasive procedure. The ShortCut is designed to protect your coronary arteries—the vessels that supply blood to your heart—during this valve replacement.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial tests a new device (EmStop) that helps protect your brain during TAVR (a type of heart valve replacement). The device is placed in arteries to catch any debris that might break loose during the procedure, potentially reducing the risk of stroke.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.